Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer

Figure 2

99mTc sestamibi SPECT analysis and histological evaluation of a triple-negative breast cancer. (a) Image showing the uptake of sestamibi in a cancer lesion characterized by a high proliferation rate (Ki67). Immunohistochemical analysis displaying triple-negative phenotypes of breast lesions: (b) ER negative; (c) PR negative; (d) HER2 score 0.